Connection

Daynna Wolff to Evidence-Based Medicine

Back to Details
This is a "connection" page, showing publications Daynna Wolff has written about Evidence-Based Medicine.
Daynna Wolff
Connection Strength
0.704
Evidence-Based Medicine
  1. Assessing Genomic Copy Number Alterations as Best Practice for Renal Cell Neoplasia: An Evidence-Based Review from the Cancer Genomics Consortium Workgroup. Cancer Genet. 2020 06; 244:40-54.
    View in: PubMed
    Score: 0.575
  2. Assessing copy number aberrations and copy-neutral loss-of-heterozygosity across the genome as best practice: An evidence-based review from the Cancer Genomics Consortium (CGC) working group for chronic lymphocytic leukemia. Cancer Genet. 2018 12; 228-229:236-250.
    View in: PubMed
    Score: 0.129
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.